Breaking News
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Dysfunction of single gene leads to miscarriages
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
October 19, 2018 - Speech Pathology Australia raises awareness about Developmental Language Disorder
October 19, 2018 - Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers
October 19, 2018 - Survey finds high prevalence of HTLV-1 infection among teens and adults in Gabon
October 19, 2018 - Bliss funds research to find whether parental touch can help alleviate pain in premature infants
October 19, 2018 - Human neurons employ highly compartmentalized signaling, study shows
October 19, 2018 - Ultromics expands multiple clinical trials for coronary heart disease to the U.S.
October 19, 2018 - $11 million NIH grant for Clemson University helps launch new center for musculoskeletal research
October 19, 2018 - A new approach identified to control Zika virus, dengue fever
October 19, 2018 - Head Blows Without Concussion May Not Damage Brain, Study Claims
October 19, 2018 - US opioid use not declined, despite focus on abuse and awareness of risk
October 19, 2018 - Next-generation RNA sequencing technology sheds new light on human mitochondrial diseases
October 19, 2018 - UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery
October 19, 2018 - The immune system also plays a key role in day-to-day function of healthy organs
October 19, 2018 - New tool may reveal how the brain structure impacts brain activity, human behavior
October 19, 2018 - Trump Administration announces ‘Winning on Reducing Food Waste’ initiative
October 19, 2018 - For-profit nursing home residents more likely to experience health issues caused by substandard care
October 19, 2018 - Incidence of stroke has risen steadily among marijuana users, show studies
October 19, 2018 - Conceptual framework proposed to examine role of exercise in multiple sclerosis
October 19, 2018 - Near infrared spectroscopy technique for accurate evaluation of chondral injuries
October 19, 2018 - Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
October 19, 2018 - Shorter physician encounters associated with antibiotic prescribing
October 19, 2018 - In the Spotlight: Enjoying research and exploring opportunities
October 19, 2018 - Physical activity lowers cardiovascular mortality risk in frail older adults
October 19, 2018 - New imaging tool helps visualize how sound-induced vibrations travel through the ear
October 19, 2018 - Key insights into the application, production of bioactive materials
October 19, 2018 - New urea sorbent could speed up the development of wearable artificial kidney
October 19, 2018 - Intensive care patients’ muscles less able to use fats for energy
October 19, 2018 - FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain
October 19, 2018 - 48,XXXY syndrome – Genetics Home Reference
October 19, 2018 - Physical exercise improves the elimination of toxic proteins from muscles
October 19, 2018 - How a new system improved wait times for Stanford kidney transplant patients
October 19, 2018 - Nutrition has bigger positive impact on bone mass and strength than exercise
October 19, 2018 - Study finds lack of progress in media representation of nurses over last 20 years
October 19, 2018 - Many people have trouble understanding differences between OCD and OCPD
October 19, 2018 - New family planning app found to be as effective as modern methods
How “sleeper cells” in cancerous tumours can be destroyed

How “sleeper cells” in cancerous tumours can be destroyed

image_pdfDownload PDFimage_print
Detecting “sleeper cells”: drug-tolerant cells (without a coloured nucleus) can be distinguished from active, dividing tumour cells (red or green nuclei) using new markers. Credit: University of Bern

In many metastasised types of cancer, disseminated tumours grow back despite successful chemotherapy. As a research team under the direction of the University of Bern, Switzerland, has now discovered, this is because of isolated cancer cells that survive the chemotherapy due to a phase of dormancy. If these “sleeper cells” possess specific defects, however, they can be destroyed. This could increase the efficacy of chemotherapy for certain patients.

Many people have experienced this among their family, friends or acquaintances: at first, the chemotherapy is extremely effective in cancer patients, although the tumour has metastasised, i.e. it has settled in remote tissue. In some cases the cancer even seems to have been eradicated. But then comes the disillusioning news: a few cancer cells have survived and are multiplying again. Sometimes they respond to renewed treatment, but then develop a resistance against all methods of therapy.

“We are interested in the question of how individual cells can survive the therapy,” says Sven Rottenberg of the Vetsuisse Faculty of the University of Bern. An international research team under his direction has now identified so-called sleeper cells that escape treatment. Because chemotherapies are especially aimed at active, dividing tumour cells, some of these sleeper cells can survive by means of a short pause in their growth. After the therapy has ended, they then start to multiply again. If, however, these sleeper cells have a specific mutation that prevents them from repairing damage to their own DNA, they can be destroyed in a targeted way using anti-cancer drugs. The study has now been published in the journal Clinical Cancer Research.

Possible alternatives to immunotherapy

If tumours grow back again after a treatment, they sometimes react to the same chemotherapy again. In that case, they have not acquired so-called “secondary resistance”, because then they would simply continue to grow in the event of repeated therapy. “We refer to the few remaining tumour cells, which survive chemotherapy, as so-called ‘drug-tolerant cells’,” says Rottenberg. How can one destroy these remaining cells? “For certain types of cancer, such as leukaemia and melanoma, enormous progress has already been made in the field of immunotherapy. This is characterised by the targeted strengthening of the body’s own immune cells, unlike in chemotherapy, in which the aim is direct destruction of the cancer cells. With this strengthening of the immune system, directed against the cancer cells, the drug-tolerant cells can also be eliminated in some patients.” According to Rottenberg, this new immunotherapy has been only modestly successful when used on other frequent tumours such as breast cancer– also, it results in side-effects and enormous costs.

Now, the researchers have discovered an alternative in a mouse model: in the case of breast tumours with a specific defect in DNA repair, the animals can be cured using already established, cheap chemotherapy drugs, if enough DNA damage can be inflicted on the resting tumour cells. Rottenberg hopes that in the future, based on these findings, the treatment of breast, ovarian and prostate cancer can be improved.

Defect in DNA repair as cancer cells’ Achilles heel

The background to this is the progress achieved in the field of personalised medicine. Types of cancer are no longer divided up and treated according to the origin of the tissue; instead, targeted analyses (such as the sequencing of genes or examination for the presence of certain proteins) are carried out to detect individual mutations that can be exploited in the therapy. Defects in DNA repair are one example. They occur due to a malfunction of proteins that repair DNA damage in normal body cells. If these proteins are inactive – which is the case in many patients with breast, ovarian or prostate cancer – the result is a flawed repair. This can be exploited in the therapy, as Rottenberg explains: “DNA-repair-defective sleeper cells respond to particular substances that damage DNA.” These substances affect healthy cells as well as the cancer. Unlike normal cells, however, the tumour cells are considerably more sensitive, because they cannot repair damage well. In the animal model, so-called DNA crosslinkers have shown to be very efficient at this. These have already been on the market for a long time, but have not previously been used for types of cancer with such defects.

Like most anti-cancer drugs, these substances also have strong side-effects such as bone-marrow damage. With certain patients, however, these side-effects could be balanced out with stem-cell transplants, as in leukaemia treatments. “Initial clinical tests in the Netherlands have shown that some breast cancer patients with metastasised breast cancer were actually cured by such intensified chemotherapy,” says Rottenberg.


Explore further:
Genetic targets to chemo-resistant breast cancer identified

More information:
Marina Pajic et al. Selected Alkylating Agents Can Overcome Drug Tolerance of G 0 -like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice, Clinical Cancer Research (2017). DOI: 10.1158/1078-0432.CCR-17-1279

Journal reference:
Clinical Cancer Research

Provided by:
University of Bern

Tagged with:

About author

Related Articles